Journal ArticleOpen Access
End COVID-19 in low- and middle-income countries
Authors
Author Affiliations
Yale University, John F. Kennedy University, Harvard University, Massachusetts Institute of Technology, ...
Published InScience
Year2022
Citations86
Abstract
Vaccines are changing the course of the COVID-19 pandemic, but in grossly uneven ways. Low- and middle-income countries (LMICs) face considerable obstacles in both receiving and distributing doses. To limit virus transmission, its devastating impacts, and opportunities for further mutations, this must change. Until it does, nonpharmaceutical interventions such as masking must remain a priority. Science invited global experts to highlight research and innovations aimed at quickening the end of COVID-19 in LMICs.
View at Publisher
BORR does not host full-text PDFs. The button above takes you to the original publisher.